首頁 > 市場調查報告書 > 醫療設備

體外診斷

乳膠過敏市場規模、佔有率和成長分析（按診斷類型、暴露類型、反應類型、治療類型、應用和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1902032

乳膠過敏市場規模、佔有率和成長分析（按診斷類型、暴露類型、反應類型、治療類型、應用和地區分類）－2026-2033年產業預測

Latex Allergy Market Size, Share, and Growth Analysis, By Diagnosis Type (Allergy Test, Skin Test), By Exposure Type, By Reaction Type, By Treatment Type, By Application, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 220 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球乳膠過敏市場規模將達到 18.3 億美元，到 2025 年將達到 19.6 億美元，到 2033 年將達到 35 億美元，在預測期（2026-2033 年）內，複合年成長率為 7.5%。

受一次性乳膠製品消費量不斷成長的推動，全球乳膠過敏市場預計將迎來顯著成長。乳膠過敏是由接觸天然橡膠乳膠引起的，會引發免疫反應，將無害蛋白質誤認為潛在威脅。這會導致抗體和抗組織胺物質的釋放，進而引發搔癢、皮疹、蕁麻疹和濕疹等症狀，進一步加重皮膚狀況。乳膠過敏的發生率在經常使用乳膠製品的人群中尤其顯著，並導致氣喘和鼻炎等相關疾病的發生率上升。人們對這些健康問題的日益關注以及對乳膠製品依賴性的增強，推動了市場顯著成長，凸顯了對有效管理方法和替代方案的迫切需求。

全球乳膠過敏市場成長要素

推動全球乳膠過敏市場成長的關鍵因素是全球乳膠過敏發生率的上升。這一激增歸因於人們接觸乳膠產品的機會增多，尤其是在醫療機構中，以及公眾對該疾病的意識提高。此外，診斷技術的進步提高了乳膠過敏的識別和檢測準確性，進一步促進了市場擴張。隨著公眾意識的增強和確診病例的增加，市場對有效解決方案和管理方案的需求預計將進一步成長，凸顯了創新和支持的重要性。

限制全球乳膠過敏市場發展的因素

全球乳膠過敏市場面臨的主要挑戰之一是乳膠過敏診斷和治療的高成本。諸如特異性IgE檢測和現代皮膚點刺試驗等先進診斷方法往往價格昂貴，這可能會限制低收入地區人口獲得這些服務的機會。這種經濟障礙削弱了全面過敏管理方案的普及，並阻礙了整體市場成長。因此，不斷上漲的成本造成了獲得必要醫療保健的機會不均等，限制了受影響人群及時獲得診斷和有效治療的能力，最終阻礙了全球乳膠過敏市場的擴張。

全球乳膠過敏市場趨勢

全球乳膠過敏市場正經歷醫療保健領域意識的不斷提高，並顯著轉向預防策略。乳膠過敏的普遍性，尤其是在醫護人員、手術病患以及經常接觸含乳膠醫療設備的人中，促使醫療機構採用更安全的替代方案和更嚴格的通訊協定。隨著醫療界日益重視患者和員工的安全，對非乳膠產品的需求激增，推動了材料創新並加強了法規結構。這種對過敏反應日益成長的關注，營造了一種以最大限度減少醫療保健應用中乳膠暴露為核心的新氛圍。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Ansell Limited（Australia）
Top Glove Corporation Bhd（Malaysia）
Hartalega Holdings Berhad（Malaysia）
Supermax Corporation Berhad（Malaysia）
Cardinal Health（USA）
Medline Industries, LP（USA）
Semperit AG Holding（Austria）
Thermo Fisher Scientific（USA）
Siemens Healthineers AG（Germany）
Danaher Corporation（USA）
ALK-Abello A/S（Denmark）
Mylan NV（now Viatris Inc.）（USA）
Sanofi SA（France）
GlaxoSmithKline plc（UK）

結論與建議

簡介目錄

Product Code: SQMIG35I2328

Global Latex Allergy Market size was valued at USD 1.83 Billion in 2024 and is poised to grow from USD 1.96 Billion in 2025 to USD 3.5 Billion by 2033, growing at a CAGR of 7.5% during the forecast period (2026-2033).

The global latex allergy market is poised for substantial growth, driven by the rising consumption of latex disposable products. This allergy stems from exposure to natural rubber latex, leading to an immune response characterized by the body identifying harmless proteins as potential threats. Consequently, antibodies and antihistamines are released, resulting in symptoms such as itching, rashes, hives, and eczema, which can further exacerbate skin conditions. The growing prevalence of latex allergies is especially notable in populations regularly using latex products, contributing to increased incidents of related conditions like asthma and rhinitis. As awareness of these health issues expands, alongside a greater reliance on latex supplies, the market is witnessing a significant upward trajectory, underscoring an urgent need for effective management and alternatives.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Latex Allergy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Latex Allergy Market Segments Analysis

Global Latex Allergy Market is segmented by Diagnosis Type, Exposure Type, Reaction Type, Treatment Type, Application and region. Based on Diagnosis Type, the market is segmented into Allergy Test and Skin Test. Based on Exposure Type, the market is segmented into Food Containing Latex Substances, Latex Gloves and Others. Based on Reaction Type, the market is segmented into Allergic Contact Dermatitis, Synthetic Reaction and Others. Based on Treatment Type, the market is segmented into Allergy Medication and Epinephrine Injection. Based on Application, the market is segmented into Allergic Contact Dermatitis, Systemic Reaction and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Latex Allergy Market

A significant factor propelling the growth of the global latex allergy market is the rising incidence of latex allergies across the globe. This surge can be attributed to heightened exposure to latex products, particularly in healthcare environments, combined with growing public awareness about the condition. Additionally, advancements in diagnostic techniques have led to improved identification and detection of latex allergies, further contributing to the market's expansion. As awareness continues to rise and more individuals are diagnosed, the demand for effective solutions and management options in the latex allergy market is expected to grow, reflecting a critical need for innovation and support.

Restraints in the Global Latex Allergy Market

One significant challenge facing the global latex allergy market is the high cost associated with the diagnosis and treatment of latex allergies. Advanced diagnostic methods, such as targeted IgE testing and modern skin prick tests, tend to be expensive, which can restrict access for individuals in lower-income regions. This financial barrier undermines the availability of comprehensive allergy management programs, thereby hindering overall market growth. Consequently, the elevated costs create disparities in access to necessary medical care, limiting the ability of affected individuals to receive timely diagnoses and effective treatments, and ultimately impeding the expansion of the latex allergy market on a global scale.

Market Trends of the Global Latex Allergy Market

The Global Latex Allergy market is witnessing a notable shift towards heightened awareness and preventive strategies within healthcare settings. The prevalence of latex allergies, particularly among healthcare professionals, surgical patients, and those frequently exposed to latex-containing medical equipment, is prompting institutions to adopt safer alternatives and stringent protocols. As the medical community increasingly prioritizes patient and staff safety, demand for non-latex products is surging, driving innovations in materials and strengthening regulatory frameworks. This growing concern for allergic reactions is fostering an environment where proactive measures are essential, leading to a redefined landscape focused on minimizing latex exposure across healthcare applications.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Latex Allergy Market Size by Diagnosis Type & CAGR (2026-2033)

Market Overview
Allergy Test
Skin Test

Global Latex Allergy Market Size by Exposure Type & CAGR (2026-2033)

Market Overview
Food Containing Latex Substances
Latex Gloves
Others

Global Latex Allergy Market Size by Reaction Type & CAGR (2026-2033)

Market Overview
Allergic Contact Dermatitis
Synthetic Reaction
Others

Global Latex Allergy Market Size by Treatment Type & CAGR (2026-2033)

Market Overview
Allergy Medication
Epinephrine Injection

Global Latex Allergy Market Size by Application & CAGR (2026-2033)

Market Overview
Allergic Contact Dermatitis
Systemic Reaction
Others

Global Latex Allergy Market Size & CAGR (2026-2033)

North America (Diagnosis Type, Exposure Type, Reaction Type, Treatment Type, Application)
- US
- Canada
Europe (Diagnosis Type, Exposure Type, Reaction Type, Treatment Type, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Diagnosis Type, Exposure Type, Reaction Type, Treatment Type, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Diagnosis Type, Exposure Type, Reaction Type, Treatment Type, Application)
- Brazil
- Rest of Latin America
Middle East & Africa (Diagnosis Type, Exposure Type, Reaction Type, Treatment Type, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Ansell Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Top Glove Corporation Bhd (Malaysia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hartalega Holdings Berhad (Malaysia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Supermax Corporation Berhad (Malaysia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medline Industries, LP (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Semperit AG Holding (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ALK-Abello A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V. (now Viatris Inc.) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments